These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6869955)

  • 21. Muscle tissue kinetics of oxytetracycline following intramuscular and oral administration at two dosages to giant freshwater shrimp (Macrobrachium rosenbergii).
    Poapolathep A; Poapolathep S; Jermnak U; Imsilp K; Wannapat N; Sugita-Konishi Y; Kumagai S
    J Vet Pharmacol Ther; 2008 Dec; 31(6):517-22. PubMed ID: 19000273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bioavailability and pharmacokinetics of 14C-cyproterone acetate after administration as a 50-mg tablet (author's transl)].
    Speck U; Jentsch D; Kühne G; Schulze PE; Wendt H
    Arzneimittelforschung; 1976; 26(9):1717-20. PubMed ID: 1036708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of pidotimod in rats and dogs.
    Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of levamisole in broiler breeder chickens.
    El-Kholy H; Kemppainen B; Ravis W; Hoerr F
    J Vet Pharmacol Ther; 2006 Feb; 29(1):49-53. PubMed ID: 16420302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodisposition of thiamphenicol in rabbits.
    Abd El-Aty AM; Abo El Sooud K; Goudah AM
    Dtsch Tierarztl Wochenschr; 2001 Sep; 108(9):393-6. PubMed ID: 11599443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of butorphanol in horses after intramuscular injection.
    Sellon DC; Papich MG; Palmer L; Remund B
    J Vet Pharmacol Ther; 2009 Feb; 32(1):62-5. PubMed ID: 19161457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and metabolism of nateglinide in humans.
    Weaver ML; Orwig BA; Rodriguez LC; Graham ED; Chin JA; Shapiro MJ; McLeod JF; Mangold JB
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):415-21. PubMed ID: 11259325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs.
    Biehl ML; Prelusky DB; Koritz GD; Hartin KE; Buck WB; Trenholm HL
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):152-9. PubMed ID: 8337696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levamisole pharmacokinetics and bioavailability in dogs.
    Watson AD; Sangster NC; Church DB; Van Gogh H
    Res Vet Sci; 1988 Nov; 45(3):411-3. PubMed ID: 3212292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of [14C]avitriptan in rats and humans.
    Marathe PH; Greene DS; Barbhaiya RH
    Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-performance liquid chromatography method for determination of flunixin in bovine plasma and pharmacokinetics after single and repeated doses of the drug.
    Odensvik K; Johansson IM
    Am J Vet Res; 1995 Apr; 56(4):489-95. PubMed ID: 7785828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.